References
- Abdollah F, Briganti A, Suardi N, et al (2011). Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? Prostate Cancer Prostatic Dis, 14, 74-8. https://doi.org/10.1038/pcan.2010.41
- Antonelli JA, Jones LW, Banez LL, et al (2009). Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy. J Urol, 182, 2226-31. https://doi.org/10.1016/j.juro.2009.07.028
- Avci CB, Harman E, Dodurga Y, et al (2013). Therapeutic potential of an anti-diabetic drug, metformin: alteration of miRNA expression in prostate cancer cells. Asian Pac J Cancer Prev, 14, 765-8. https://doi.org/10.7314/APJCP.2013.14.2.765
- Balasubramaniam G, Talole S, Mahantshetty U, Saoba S, Shrivastava S (2013). Prostate cancer: a hospital-based survival study from Mumbai, India. Asian Pac J Cancer Prev, 14, 2595-8. https://doi.org/10.7314/APJCP.2013.14.4.2595
- Berger AP, Deibl M, Halpern EJ, et al (2005). Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia. Diabetologia, 48,784-9. https://doi.org/10.1007/s00125-005-1678-6
- Bonovas S, Filioussi K, Tsantes A (2004). Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia 47, 1071-8.
- Chan JM, Latini DM, Cowan J, Duchane J, Carroll PR (2005). History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States). Cancer Causes Control, 16, 789-97. https://doi.org/10.1007/s10552-005-3301-z
- Demir U, Koehler A, Schneider R, et al (2014). Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells. BMC Cancer. 31, 14-52.
- Epstein JI, Allsbrook WC Jr, Amin MB, et al (2005). The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol, 29, 1228-42. https://doi.org/10.1097/01.pas.0000173646.99337.b1
- Fall K, Garmo H, Gudbjornsdottir S, et al (2013). Diabetes mellitus and prostate cancer risk; a nationwide casecontrol study within PCBaSe Sweden. Cancer Epidemiol Biomarkers Prev, 22, 1102-9. https://doi.org/10.1158/1055-9965.EPI-12-1046
- Fowke JH, Motley SS, Cookson MS, et al (2007). The association between body size, prostate volume and prostate-specific antigen. Prostate Cancer Prostatic Dis, 10, 137-42. https://doi.org/10.1038/sj.pcan.4500924
- Fukushima H, Masuda H, Kawakami S, et al (2012). Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10ng/mL. Urology, 79, 1329-35. https://doi.org/10.1016/j.urology.2012.01.070
- Gong Z, Neuhouser ML, Goodman PJ, et al (2006). Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev, 15, 1977-83. https://doi.org/10.1158/1055-9965.EPI-06-0477
- Hammarsten J, Hogstedt B (2001). Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol, 39, 151-8. https://doi.org/10.1159/000052430
- Hong SK, Oh JJ, Byun SS, et al (2011). Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (_12)-core prostate biopsy. Prostate, 72, 51-7.
- Jayachandran J, Aronson WJ, Terris MK, et al (2010). Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database. Cancer Epidemiol Biomarkers Prev, 19, 9-17. https://doi.org/10.1158/1055-9965.EPI-09-0777
- Kang J, Chen MH, Zhang Y, et al (2012). Type of diabetes mellitus and the odds of Gleason score 8-10 prostate cancer. Int J Radiat Oncol Biol Phys, 82, 463-7. https://doi.org/10.1016/j.ijrobp.2010.10.001
- Kasper JS, Giovannucci E (2006). A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 15, 2056-62. https://doi.org/10.1158/1055-9965.EPI-06-0410
- Kim H, Presti JC Jr, Aronson WJ, et al (2010). Glycemic control and prostate cancer progression: results from the search database. Prostate, 70, 1540-6. https://doi.org/10.1002/pros.21189
- Leitzmann MF, Ahn J, Albanes D, et al (2008). Diabetes mellitus and prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Causes Control, 19, 1267-76. https://doi.org/10.1007/s10552-008-9198-6
- Long XJ, Lin S, Sun YN, Zheng ZF (2012). Diabetes mellitus and prostate cancer risk in Asian countries: a meta-analysis. Asian Pac J Cancer Prev, 13, 4097-100. https://doi.org/10.7314/APJCP.2012.13.8.4097
- Lu K, Song XL, Han SL, Wang CH, Zhong N, Qi LF (2014). Potential study perspectives on mechanisms and correlations between adiposity and malignancy. Asian Pac J Cancer Prev, 15, 1057-60. https://doi.org/10.7314/APJCP.2014.15.2.1057
- McGrowder DA, Jackson LA, Crawford TV (2012). Prostate cancer and metabolic syndrome: is there a link? Asian Pac J Cancer Prev, 13, 1-13. https://doi.org/10.7314/APJCP.2012.13.1.001
- Moreira DM, Anderson T, Gerber L, et al (2011). The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series. Cancer Causes Control, 22, 977-83. https://doi.org/10.1007/s10552-011-9770-3
- Muller H, Raum E, Rothenbacher D, Stegmaier C, Brenner H (2009). Association of diabetes and body mass index with levels of prostate-specific antigen: implications for correction of prostate-specific antigen cutoff values? Cancer Epidemiol Biomarkers Prev, 18, 1350-6. https://doi.org/10.1158/1055-9965.EPI-08-0794
- Oliver SE, Gunnell D, Donovan J, et al (2004). Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study. Int J Cancer, 108, 887-92. https://doi.org/10.1002/ijc.11631
- Pierce BL, Plymate S, Ostrander EA, Stanford JL (2008). Diabetes mellitus and prostate cancer risk. Prostate, 68, 1126-32. https://doi.org/10.1002/pros.20777
- Turgutalp K, Ozhan O, Helvaci I, et al (2013). Serum levels of cancer biomarkers in diabetic and non-diabetic proteinuric patients: a preliminary study. Clin Chem Lab Med, 51, 889-95.
- Van Praet C, Libbrecht L, D'Hondt F, et al (2013). Agreement of gleason score on prostate biopsy and radical prostatectomy specimen: is there improvement with increased number of biopsy cylinders and the 2005 revised gleason scoring? Clin Genitourin Cancer, [Epub ahead of print].
- Vigneri P, Frasca F, Sciacca L, et al (2009). Diabetes and cancer. Endocr Relat Cancer, 16, 1103-23. https://doi.org/10.1677/ERC-09-0087
- Wallner LP, Morgenstern H, McGree ME, et al (2011). The effects of type 2 diabetes and hypertension on changes in serum prostate specific antigen levels: results from the Olmsted county study. Urology, 77, 137-41. https://doi.org/10.1016/j.urology.2010.07.516
- Waters KM, Henderson BE, Stram DO, et al (2009). Association of diabetes with prostate cancer risk in the multiethnic cohort. Am J Epidemiol, 169, 937-45. https://doi.org/10.1093/aje/kwp003
- Werny DM, Saraiya M, Gregg EW (2006). Prostate-specific antigen values in diabetic and nondiabetic US men, 2001- 2002. Am J Epidemiol, 164, 978-83. https://doi.org/10.1093/aje/kwj311
- Woo HY, Park H, Kwon MJ, Chang Y, Ryu S (2012). Association of prostate specific antigen concentration with lifestyle characteristics in Korean men. Asian Pac J Cancer Prev, 13, 5695-9. https://doi.org/10.7314/APJCP.2012.13.11.5695
- Wu C, Moreira DM, Gerber L, et al (2011). Diabetes and prostate cancer risk in the REDUCE trial. Prostate Cancer Prostatic Dis, 14, 326-31. https://doi.org/10.1038/pcan.2011.28
- Xu H, Mao SH, Ding GX, Ding Q, Jiang HW (2013). Diabetes mellitus reduces prostate cancer risk - no function of age at diagnosis or duration of disease. Asian Pac J Cancer Prev, 14, 441-7. https://doi.org/10.7314/APJCP.2013.14.1.441
Cited by
- Prostate-Specific Antigen Levels in Relation to Background Factors: Are there Links to Endocrine Disrupting Chemicals and AhR Expression? vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6121
- Poor Glycemic Control of Diabetes Mellitus Is Associated with Higher Risk of Prostate Cancer Detection in a Biopsy Population vol.9, pp.9, 2014, https://doi.org/10.1371/journal.pone.0104789
- Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study vol.20, pp.3, 2017, https://doi.org/10.1038/pcan.2017.14
- Diabetes-induced hyperglycemia impairs male reproductive function: a systematic review vol.24, pp.1, 2017, https://doi.org/10.1093/humupd/dmx033